Skip to main content
Go back to Resources
Subcutaneously administered daclizumab (SC-DAC, humanized anti-IL-2 receptor antibody) therapy for uveitis
2003
Journal Article
Authors:
Nussenblatt, R.B.
Rao, N.A.
Foster, C.S.
Sen, H.N.
Srivastava, S.
Ursea, R.
Li, Z.
Thompson, D.J.
Peterson, J.S.
Robinson, R.R.
Shames, R.S.
Buggage, R.R.
Location:
Anaheim, CA
Go back to Resources